By sinha on 7, October, 2008 | Channel: Funding

Biotech Company GangaGen raises $1.8mn

Bangalore (and US) based Biotech research company, GangaGen has raised $1.8mn from ATEL ventures.

The funding will be used to develop treatments for antibiotic-resistant bacterial infections like MRSA, a skin infection that plagues hospitals, and pneumonia (via)

Recommended Read: Green Tech Investments in India | The Great Indian Energy Innovation!

 

  • Related Articles

    1. Investors shifting focus from IT to BioTech, Logistics, Cleantech, Film Production and Education
    2. Company Culture – What kind of a company do you wish to build?
    3. NVP and Reliance Technology Venture Invest in Suvidhaa, S-Commerce Company
    4. Breaking: SMSGupshup/Webaroo Raises $10mn Funding
    5. Interesting Orkut Hack
    • comment(s) on Biotech Company GangaGen raises $1.8mn

    One Response to Biotech Company GangaGen raises $1.8mn

    1. Leo says:
      October 7, 2008 at 1:58 PM

      Seems like they are into a very good niche which will solve a major global health problem.(Hospital based MRSA infections). A country like India loses huge number of ‘otherwise healthy’ patients just due to this problem.

      Heartening to see Indian bio-companies stepping into such basic r&D to come up with innovative biotech therapeutics. Though, I wonder how much time it would take to clear DCGI regulatory approval for Phage based therapeutics in India.

      Reply